Search

Author/Creator Labianca, Roberto

2. Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy. Issue 8 (10th January 2013)

Authors:
Sinicrope, Frank A.; Foster, Nathan R.; Yothers, Greg; Benson, Al; Seitz, Jean Francois; Labianca, Roberto; Goldberg, Richard M.; DeGramont, Aimery; O'Connell, Michael J.; Sargent, Daniel J.; for the Adjuvant Colon Cancer Endpoints (ACCENT) Group
Journal:
Cancer
Issue:
Volume 119:Issue 8(2013)
Page Start:
1528
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy. Issue 8 (10th January 2013)

Authors:
Sinicrope, Frank A.; Foster, Nathan R.; Yothers, Greg; Benson, Al; Seitz, Jean Francois; Labianca, Roberto; Goldberg, Richard M.; DeGramont, Aimery; O'Connell, Michael J.; Sargent, Daniel J.
Journal:
Cancer
Issue:
Volume 119:Issue 8(2013)
Page Start:
1528
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group. (September 2018)

Authors:
Goey, Kaitlyn K.H.; Sørbye, Halfdan; Glimelius, Bengt; Adams, Richard A.; André, Thierry; Arnold, Dirk; Berlin, Jordan D.; Bodoky, György; de Gramont, Aimery; Díaz-Rubio, Eduardo; Eng, Cathy; Falcone, Alfredo; Grothey, Axel; Heinemann, Volker; Hochster, Howard S.; Kaplan, Richard S.; Kopetz, Scot...
Journal:
European journal of cancer
Issue:
Volume 100(2018)
Page Start:
35
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease. Issue 3 (March 2018)

Authors:
ter Veer, Emil; van Rijssen, L Bengt; Besselink, Marc G; Mali, Rosa M A; Berlin, Jordan D; Boeck, Stefan; Bonnetain, Franck; Chau, Ian; Conroy, Thierry; Van Cutsem, Eric; Deplanque, Gael; Friess, Helmut; Glimelius, Bengt; Goldstein, David; Herrmann, Richard; Labianca, Roberto; Van Laethem, Jean-L...
Journal:
Lancet oncology
Issue:
Volume 19:Issue 3(2018)
Page Start:
e151
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Duration of Adjuvant Doublet Chemotherapy (3 or 6 months) in Patients With High-Risk Stage II Colorectal Cancer. Issue 6 (20th February 2021)

Authors:
Iveson, Timothy J.; Sobrero, Alberto F.; Yoshino, Takayuki; Souglakos, Ioannis; Ou, Fang-Shu; Meyers, Jeffrey P.; Shi, Qian; Grothey, Axel; Saunders, Mark P.; Labianca, Roberto; Yamanaka, Takeharu; Boukovinas, Ioannis; Hollander, Niels H.; Galli, Fabio; Yamazaki, Kentaro; Georgoulias, Vassilis; K...
Journal:
Journal of clinical oncology
Issue:
Volume 39:Issue 6(2021)
Page Start:
631
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Early-Onset Colorectal Adenocarcinoma in the IDEA Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and Oxaliplatin. Issue 36 (20th December 2021)

Authors:
Fontana, Elisa; Meyers, Jeff; Sobrero, Alberto; Iveson, Timothy; Shields, Anthony F.; Taieb, Julien; Yoshino, Takayuki; Souglakos, Ioannis; Smyth, Elizabeth C.; Lordick, Florian; Moehler, Markus; Giraut, Anne; Harkin, Andrea; Labianca, Roberto; Meyerhardt, Jeffrey; André, Thierry; Boukovinas, Ioa...
Journal:
Journal of clinical oncology
Issue:
Volume 39:Issue 36(2021)
Page Start:
4009
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗